tiprankstipranks
Trending News
More News >
Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ:ELDN
US Market

Eledon Pharmaceuticals (ELDN) Income Statement

Compare
1,013 Followers

Eledon Pharmaceuticals Income Statement

Last quarter (Q4 2025), Eledon Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Eledon Pharmaceuticals's net income was $-10.45M. See Eledon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -359.00K$ -374.00K$ -373.00K$ -195.00K
Operating Expenses
$ 83.25M$ 70.22M$ 42.63M$ 39.41M$ 36.67M
Depreciation and Amortization
$ 0.00$ 359.00K$ 374.00K$ 373.00K$ 195.00K
EBITDA
$ -83.25M$ -35.39M$ -116.16M$ -87.59M$ -36.66M
Operating Income
$ -83.25M$ -70.58M$ -43.00M$ -39.78M$ -36.87M
Other Income/Expenses
$ 37.67M$ 34.82M$ -73.54M$ -48.19M$ 7.00K
Pretax Income
$ -45.58M$ -35.75M$ -116.54M$ -87.97M$ -36.86M
Net Income
$ -45.62M$ -36.18M$ -116.54M$ -87.97M$ -34.51M
Per Share Metrics
Basic EPS
$ -0.56$ -0.75$ 0.00$ -6.13$ -2.33
Diluted EPS
$ -0.56$ -0.75$ -1.64$ -6.13$ -2.33
Weighted Average Shares Outstanding
81.84M 48.54M 24.62M 14.29M 14.82M
Weighted Average Shares Outstanding (Diluted)
81.84M 48.54M 24.62M 14.29M 14.82M
Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History